XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 58,442 $ 93,120
Restricted cash 403,758 0
Marketable securities 170,126 368,214
Accounts receivable, net 143,568 165,497
Inventories, net 91,147 91,541
Prepaid expenses and other current assets 16,299 15,779
Total current assets 883,340 734,151
Long-term marketable securities 54,157 93,896
Property and equipment, net 14,611 15,173
Intangible assets, net 682,497 702,463
Goodwill 117,019 117,019
Other assets 40,184 39,806
Total assets 1,791,808 1,702,508
Current liabilities    
Accounts payable and accrued liabilities 95,345 96,342
Accrued product returns and rebates 147,852 151,665
Convertible notes, net 402,500 401,968
Line of credit 78,363 0
Contingent consideration, current portion 0 21,120
Other current liabilities 7,485 16,863
Total current liabilities 731,545 687,958
Contingent consideration, long-term 53,320 33,847
Operating lease liabilities, long-term 36,511 35,998
Deferred income tax liabilities, net 49,668 49,809
Other liabilities 8,614 8,692
Total liabilities 879,658 816,304
Stockholders’ equity    
Common stock, $0.001 par value; 130,000,000 shares authorized; 54,470,622 and 54,253,796 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 54 54
Additional paid-in capital 416,232 408,115
Accumulated other comprehensive loss, net of tax (2,329) (3,210)
Retained earnings 498,193 481,245
Total stockholders’ equity 912,150 886,204
Total liabilities and stockholders’ equity $ 1,791,808 $ 1,702,508